Good afternoon, everyone. Joining uso much for for the American Civil War symposium. Ordinary people, extraordinary times. T up on our roster where she received the 2016 great teacher award. She taught previously at the state of at the university of new york in the state of albany. She received her phd studying under dr. And dr. Gallagher. Dr. Taylor is a member of the board of editors of the journal of southern history and advisor editor for the civil war monitor magazine and coeditor of the university of Georgia Press is on civil war series. Her current book project of the manyy thousands of men and women and children who fled slavery during the civil war and examined how their day to day experiences shaped the way emancipation unfolded in the United States. Book derived from her dissertation provided family in the civil war. In 2005. Published that book is the topic of her program today. I present to you dr. Amy morel taylor. It is indeed a real pleasure to be back here in virginia,
Well keep an eye on that. Senior medical correspondent elizabeth cohen, for more on this trial, so this portion of the vaccine trial, its early. Its a small number of participants, and really focused on safety at this point, but good news is theyre not in the development of antibodies of those who took this trial vaccine. Right, so theyre focused on safety, jim, but theyre also trying to see what it does to the persons immune system, what does it actually do, and what they found was that it did get people to manufacture what are called neutralizing antibodies, so that means antibodies that bind to the virus, and here theoretically would prevent it from infecting a human cell. They found when they were in the lab it did prevent it from entering a human cell. Dr. Tolzacs, lets take a listen. This is a first important step in the Journey Towards having a zach seen available for the people who need it the most. Now safety, you mentioned that this is a trial that looks at safety. What they